These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30985435)

  • 1. Monoamine Oxidase B Binding of 18F-THK5351 to Visualize Glioblastoma and Associated Gliosis: An Autopsy-Confirmed Case.
    Tago T; Toyohara J; Sengoku R; Murayama S; Ishii K
    Clin Nucl Med; 2019 Jun; 44(6):507-509. PubMed ID: 30985435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase B inhibitor, selegiline, reduces
    Ng KP; Pascoal TA; Mathotaarachchi S; Therriault J; Kang MS; Shin M; Guiot MC; Guo Q; Harada R; Comley RA; Massarweh G; Soucy JP; Okamura N; Gauthier S; Rosa-Neto P
    Alzheimers Res Ther; 2017 Mar; 9(1):25. PubMed ID: 28359327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging-pathological correlations of [
    Ishiki A; Harada R; Kai H; Sato N; Totsune T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Iwata R; Furumoto S; Tashiro M; Sasano H; Kitamoto T; Kudo Y; Yanai K; Furukawa K; Okamura N; Arai H
    Acta Neuropathol Commun; 2018 Jun; 6(1):53. PubMed ID: 29958546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution Pattern of the Monoamine Oxidase B Ligand, 18F-THK5351, in the Healthy Brain.
    Ishibashi K; Miura Y; Tago T; Toyohara J; Higashihara M; Iwata A; Ishii K
    Clin Nucl Med; 2022 Jul; 47(7):e489-e495. PubMed ID: 35675140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-Humans Evaluation of
    Villemagne VL; Harada R; Doré V; Furumoto S; Mulligan R; Kudo Y; Burnham S; Krishnadas N; Bozinovski S; Huang K; Lopresti BJ; Yanai K; Rowe CC; Okamura N
    J Nucl Med; 2022 Oct; 63(10):1551-1559. PubMed ID: 35086898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [
    Ng KP; Therriault J; Kang MS; Struyfs H; Pascoal TA; Mathotaarachchi S; Shin M; Benedet AL; Massarweh G; Soucy JP; Rosa-Neto P; Gauthier S
    Neuroimage Clin; 2019; 24():102091. PubMed ID: 31795034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.
    Lemoine L; Gillberg PG; Svedberg M; Stepanov V; Jia Z; Huang J; Nag S; Tian H; Ghetti B; Okamura N; Higuchi M; Halldin C; Nordberg A
    Alzheimers Res Ther; 2017 Dec; 9(1):96. PubMed ID: 29229003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report.
    Kim HJ; Cho H; Park S; Jang H; Ryu YH; Choi JY; Moon SH; Oh SJ; Oh M; Na DL; Lyoo CH; Kim EJ; Seeley WW; Kim JS; Choi KC; Seo SW
    BMC Neurol; 2019 Aug; 19(1):211. PubMed ID: 31464590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-THK5351 PET Can Identify Astrogliosis in Multiple Sclerosis Plaques.
    Ishibashi K; Miura Y; Hirata K; Toyohara J; Ishii K
    Clin Nucl Med; 2020 Feb; 45(2):e98-e100. PubMed ID: 31348091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in
    Ezura M; Kikuchi A; Ishiki A; Okamura N; Hasegawa T; Harada R; Watanuki S; Funaki Y; Hiraoka K; Baba T; Sugeno N; Oshima R; Yoshida S; Kobayashi J; Kobayashi M; Tano O; Nakashima I; Mugikura S; Iwata R; Taki Y; Furukawa K; Arai H; Furumoto S; Tashiro M; Yanai K; Kudo Y; Takeda A; Aoki M
    Eur J Neurol; 2019 Sep; 26(9):1205-1211. PubMed ID: 30980575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the temporal course of astrogliosis and symptom improvement in cerebral infarction: report of a case monitored using
    Ishibashi K; Miura Y; Hirata K; Toyohara J; Ishii K
    BMC Med Imaging; 2020 Jul; 20(1):81. PubMed ID: 32664871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Use of 18F-THK5351 PET to Identify Wallerian Degeneration of the Pyramidal Tract Caused by Cerebral Infarction.
    Ishibashi K; Kameyama M; Tago T; Toyohara J; Ishii K
    Clin Nucl Med; 2017 Dec; 42(12):e523-e524. PubMed ID: 29076904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of
    Harada R; Ishiki A; Kai H; Sato N; Furukawa K; Furumoto S; Tago T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Nakamura T; Yoshikawa T; Iwata R; Tashiro M; Sasano H; Kitamoto T; Yanai K; Arai H; Kudo Y; Okamura N
    J Nucl Med; 2018 Apr; 59(4):671-674. PubMed ID: 28864633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-THK5351 PET Can Identify Lesions of Acute Traumatic Brain Injury.
    Takami Y; Yamamoto Y; Norikane T; Mitamura K; Hatakeyama T; Nishiyama Y
    Clin Nucl Med; 2020 Nov; 45(11):e491-e492. PubMed ID: 32657863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-Head Comparison of the Two MAO-B Radioligands, 18F-THK5351 and 11C-L-Deprenyl, to Visualize Astrogliosis in Patients With Neurological Disorders.
    Ishibashi K; Kameyama M; Miura Y; Toyohara J; Ishii K
    Clin Nucl Med; 2021 Jan; 46(1):e31-e33. PubMed ID: 32657879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Uptake of 18F-THK5351 in Glioblastoma But Not in Primary Central Nervous System Lymphoma.
    Mitamura K; Norikane T; Yamamoto Y; Miyake K; Nishiyama Y
    Clin Nucl Med; 2021 Sep; 46(9):772-773. PubMed ID: 34028419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of MAO-B PET using
    Ishibashi K
    Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():31-43. PubMed ID: 37973072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
    Harada R; Okamura N; Furumoto S; Furukawa K; Ishiki A; Tomita N; Tago T; Hiraoka K; Watanuki S; Shidahara M; Miyake M; Ishikawa Y; Matsuda R; Inami A; Yoshikawa T; Funaki Y; Iwata R; Tashiro M; Yanai K; Arai H; Kudo Y
    J Nucl Med; 2016 Feb; 57(2):208-14. PubMed ID: 26541774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.
    Kikuchi A; Okamura N; Hasegawa T; Harada R; Watanuki S; Funaki Y; Hiraoka K; Baba T; Sugeno N; Oshima R; Yoshida S; Kobayashi J; Ezura M; Kobayashi M; Tano O; Mugikura S; Iwata R; Ishiki A; Furukawa K; Arai H; Furumoto S; Tashiro M; Yanai K; Kudo Y; Takeda A; Aoki M
    Neurology; 2016 Nov; 87(22):2309-2316. PubMed ID: 27794115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-THK5351 Uptake May Not Estimate Neurofibrillary Tangles in In Vivo Images: A Comparison With 18F-MK-6240 Uptake.
    Ishibashi K; Tago T; Kameyama M; Toyohara J; Ishii K
    Clin Nucl Med; 2024 Aug; 49(8):754-756. PubMed ID: 38967508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.